Eastwood Bio-Medical Canada Inc.
EWOOF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Revenue | $188 | $135 | $201 | $129 |
| % Growth | 39.2% | -32.7% | 55.7% | – |
| Cost of Goods Sold | $57 | $49 | $61 | $80 |
| Gross Profit | $131 | $86 | $140 | $49 |
| % Margin | 69.5% | 63.9% | 69.8% | 38.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $147 | $116 | $139 | $120 |
| SG&A Expenses | $149 | $116 | $140 | $122 |
| Sales & Mktg Exp. | $2 | $0 | $1 | $2 |
| Other Operating Expenses | -$18 | -$30 | $0 | -$73 |
| Operating Expenses | $131 | $86 | $140 | $49 |
| Operating Income | -$101 | -$134 | -$64 | -$151 |
| % Margin | -53.8% | -99% | -31.9% | -117.2% |
| Other Income/Exp. Net | -$14 | $4 | $10 | -$33 |
| Pre-Tax Income | -$116 | -$130 | -$54 | -$184 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$116 | -$130 | -$54 | -$184 |
| % Margin | -61.4% | -96.3% | -27% | -142.7% |
| EPS | -0.001 | -0.001 | -0.001 | -0.002 |
| % Growth | 14.3% | -133.3% | 68.4% | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.002 |
| Weighted Avg Shares Out | 68,920 | 68,891 | 68,916 | 68,898 |
| Weighted Avg Shares Out Dil | 68,886 | 68,886 | 68,886 | 68,886 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $2 | -$1 | $20 |
| Depreciation & Amortization | $27 | $27 | $27 | $27 |
| EBITDA | -$75 | -$107 | -$37 | -$138 |
| % Margin | -39.6% | -79.3% | -18.6% | -106.6% |